Thread by @sailorrooscout

Some good news for your day! The latest real-world study from Public Health England (PHE) shows that both Pfizer’s AND Oxford-AstraZeneca’s vaccines are both highly effective in reducing SARS-CoV-2 infections among older people aged 70 years and over.
khub.net/documents/1359…

Since January, protection against symptomatic COVID, 4 weeks after the first dose, ranged between 57 and 61% for one dose of Pfizer’s vaccine and between 60 and 73% for Oxford-AstraZeneca’s vaccine. Their data shows symptomatic infections in those over 70 decreasing from around 3

weeks after one dose of either vaccine. In those over 80, study data suggested a single dose of either vaccine is more than 80% effective at preventing hospitalization, around 3 to 4 weeks post immunization. Evidence also suggests Pfizer’s vaccine, leads to an 83% reduction in

deaths from COVID-19. Make no mistake these studies continue to provide further evidence these vaccines are working and are highly effective in protecting us against severe disease, hospitalization, and death.

And if you want some more data on the effectiveness of these vaccines from a previous PHE study on reduction of asymptomatic cases (because this study deserves much more attention) please see:

https://twitter.com/sailorrooscout/status/1365368469110329348

For those who were asking. It was announced that those who are over 65 in France will be able to receive Oxford/AstraZeneca vaccine after all in a change to an original decision which was because of lack of insufficient data for that age group. The good results are catching on.